Tag Archives: canada

New Edition of C.I.P.A. Guide to Patent Acts Published

Posted on April 2, 2020 by Warren Woessner

This “Guide” is a 1528 page book published by the Chartered Institute of Patent Attorneys via Thomson Reuters, and edited by Paul Cole and Richard Davis. Of course, it mostly focused on UK patent law, but draws upon a variety … Continue reading →

Posted in Non-U.S. Practice | Tagged Australia, canada, EPO | Leave a comment

Canada’s ‘’Sister” Prior Art Law Differs From Ours, Eh!

Posted on October 29, 2013 by Warren Woessner

I recently received a well-written post from Smart & Biggar/Feherstonhaugh in Toronto reminding me that a publication by the inventor only shields a later third-party publication from being a bar if the second publication was derived from the inventor and a … Continue reading →

Posted in Int'l Practice and Policy | Tagged AIA, canada, Canada IP, intellectual property, ip, IP law tools, Smart & Biggar, Warren Woessner | Leave a comment

Inequitable Conduct in Canada – Disarming the “Atomic Bomb”

Posted on July 25, 2011 by Warren Woessner

This is a guest post from Brian W. Gray of Norton Rose. This week a significant decision for patent owners was released from our Canadian Federal Court of Appeal. A copy of the case is found at the end of … Continue reading →

Posted in Inequitable Conduct/Rule 56 | Tagged biotechnology, biotechnology law, biotechnology news, brian gray, cafc, canada, canadian federal cout of appeal, intellectual property, ip, norton rose, Patent Law, patents, Therasense, Warren Woessner, weatherford appeal | 1 Comment

Canadian Ruling Supports “Antibody Exception”

Posted on March 10, 2011 by Warren Woessner

In my recent post on the Centocor v. Abbott decision, I noted that the Fed. Cir. had at least preserved the “antibody exception,” which I define as permitting broad claims to structurally uncharacterized antibodies (monoclonal and polyclonal) if the structure … Continue reading →